Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments
申请人:Walter Rainer
公开号:US20080300290A1
公开(公告)日:2008-12-04
Compounds of general formula (I)
which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are:
[4-(1-3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)-phenyl]-acetic acid and
methyl [4-(1-3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)-phenyl]-acetate.